{"id":446578,"date":"2021-03-01T06:03:25","date_gmt":"2021-03-01T11:03:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=446578"},"modified":"2021-03-01T06:03:25","modified_gmt":"2021-03-01T11:03:25","slug":"ideaya-to-participate-in-upcoming-march-2021-investor-relations-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/","title":{"rendered":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SOUTH SAN FRANCISCO, Calif.<\/span>, <span class=\"xn-chron\">March 1, 2021<\/span> \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations events.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" title=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" alt=\"(PRNewsfoto\/IDEAYA Biosciences, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <u>Investor Relations Events<\/u>\n      <\/p>\n<ul type=\"disc\">\n<li>H.C. Wainwright Global Life Sciences Conference 2021 (Virtual)<br \/>Corporate Presentation<br \/><span class=\"xn-chron\">Tuesday, March 9<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">7:00 am ET<\/span><\/li>\n<li>Citi&#8217;s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)<br \/>Fireside Chat with Analyst <span class=\"xn-person\">Mohit Bansal<\/span><br \/><span class=\"xn-chron\">Tuesday, March 16<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">3:00 pm ET<\/span><\/li>\n<li>Oppenheimer&#8217;s 31<sup>st<\/sup> Annual Healthcare Conference (Virtual)<br \/>Company Presentation<br \/><span class=\"xn-chron\">Wednesday, March 17<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">2:30 pm ET<\/span><\/li>\n<li>Roth 33<sup>rd<\/sup> Annual Conference (Virtual)<br \/>Company Panel hosted by Analyst Zegbeh Jallah: &#8220;Highly Attractive Small Molecule <br \/>Oncology Platforms&#8221; with Arvinas, IDEAYA Biosciences and Turning Point Therapeutics<br \/><span class=\"xn-chron\">Wednesday, March 17<\/span><sup>th<\/sup>, 2021 at <span class=\"xn-chron\">5:00 pm ET<\/span><\/li>\n<\/ul>\n<p>A live audio webcast of selected events will be available by visiting the &#8220;Investors\/News and Events\/Investor Calendar&#8221; section of the IDEAYA website at\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3081133-1&amp;h=177691128&amp;u=https%3A%2F%2Fir.ideayabio.com%2Fnews-events%2Finvestor-calendar&amp;a=https%3A%2F%2Fir.ideayabio.com%2Fnews-events%2Finvestor-calendar\" rel=\"nofollow noopener noreferrer\">https:\/\/ir.ideayabio.com\/news-events\/investor-calendar<\/a>.\u00a0 A replay of selected webcasts will be available for 30 days following the live event.<\/p>\n<p>\n        <b>About IDEAYA Biosciences<\/b>\n      <\/p>\n<p>IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.\u00a0 IDEAYA&#8217;s approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies.\u00a0 IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality \u2013 which represents an emerging class of precision medicine targets.\u00a0 <\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release contains forward-looking statements, including, but not limited to, statements related to participation in and\/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA&#8217;s recent Quarterly Report on Form 10-Q filed on <span class=\"xn-chron\">November 12, 2020<\/span> and any current and periodic reports filed with the U.S. Securities and Exchange Commission.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=AQ93449&amp;sd=2021-03-01\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events-301236947.html\">http:\/\/www.prnewswire.com\/news-releases\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events-301236947.html<\/a><\/p>\n<p>SOURCE  IDEAYA Biosciences, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=AQ93449&amp;Transmission_Id=202103010600PR_NEWS_USPR_____AQ93449&amp;DateId=20210301\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SOUTH SAN FRANCISCO, Calif., March 1, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations events. Investor Relations Events H.C. Wainwright Global Life Sciences Conference 2021 (Virtual)Corporate PresentationTuesday, March 9th, 2021 at 7:00 am ET Citi&#8217;s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)Fireside Chat with Analyst Mohit BansalTuesday, March 16th, 2021 at 3:00 pm ET Oppenheimer&#8217;s 31st Annual Healthcare Conference (Virtual)Company PresentationWednesday, March 17th, 2021 at 2:30 pm ET Roth 33rd Annual Conference (Virtual)Company Panel hosted by Analyst Zegbeh Jallah: &#8220;Highly Attractive Small Molecule Oncology Platforms&#8221; with Arvinas, IDEAYA Biosciences and Turning &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IDEAYA to Participate in Upcoming March 2021 Investor Relations Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-446578","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SOUTH SAN FRANCISCO, Calif., March 1, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations events. Investor Relations Events H.C. Wainwright Global Life Sciences Conference 2021 (Virtual)Corporate PresentationTuesday, March 9th, 2021 at 7:00 am ET Citi&#8217;s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)Fireside Chat with Analyst Mohit BansalTuesday, March 16th, 2021 at 3:00 pm ET Oppenheimer&#8217;s 31st Annual Healthcare Conference (Virtual)Company PresentationWednesday, March 17th, 2021 at 2:30 pm ET Roth 33rd Annual Conference (Virtual)Company Panel hosted by Analyst Zegbeh Jallah: &#8220;Highly Attractive Small Molecule Oncology Platforms&#8221; with Arvinas, IDEAYA Biosciences and Turning &hellip; Continue reading &quot;IDEAYA to Participate in Upcoming March 2021 Investor Relations Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-01T11:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events\",\"datePublished\":\"2021-03-01T11:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/\"},\"wordCount\":371,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/\",\"name\":\"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"datePublished\":\"2021-03-01T11:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/820568\\\/IDEAYA_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/","og_locale":"en_US","og_type":"article","og_title":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk","og_description":"PR Newswire SOUTH SAN FRANCISCO, Calif., March 1, 2021 \/PRNewswire\/ &#8212; IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the following upcoming investor relations events. Investor Relations Events H.C. Wainwright Global Life Sciences Conference 2021 (Virtual)Corporate PresentationTuesday, March 9th, 2021 at 7:00 am ET Citi&#8217;s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)Fireside Chat with Analyst Mohit BansalTuesday, March 16th, 2021 at 3:00 pm ET Oppenheimer&#8217;s 31st Annual Healthcare Conference (Virtual)Company PresentationWednesday, March 17th, 2021 at 2:30 pm ET Roth 33rd Annual Conference (Virtual)Company Panel hosted by Analyst Zegbeh Jallah: &#8220;Highly Attractive Small Molecule Oncology Platforms&#8221; with Arvinas, IDEAYA Biosciences and Turning &hellip; Continue reading \"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-01T11:03:25+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events","datePublished":"2021-03-01T11:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/"},"wordCount":371,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/","name":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","datePublished":"2021-03-01T11:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/820568\/IDEAYA_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ideaya-to-participate-in-upcoming-march-2021-investor-relations-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IDEAYA to Participate in Upcoming March 2021 Investor Relations Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=446578"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/446578\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=446578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=446578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=446578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}